Hanmi Pharm. Co., Ltd.

Jong Suk Lee

Se Chang Kwon

Young Jin Park

Sung Youb Jung

Jong Min Lee

In Young Choi

Chang Ki Lim

Euh Lim Oh

Jae Hyuk Choi

Jung Kuk Kim

Hyo Sang Jo

Hyun Joo Kwon

Eun Jin Park

The present invention relates to a novel peptide of a glucagon derivative and a composition for preventing or treating obesity comprising the peptide as an active ingredient. The glucagon derivative according to the present invention shows a more excellent activating effect with regard to both glucagon-like peptide-1 receptors and glucagon receptors compared to native glucagon, and thus can be widely used as an effective agent for treating obesity.

Glucagon derivatives

A a triple agonist having activities to all of glucagon, GLP-1, and GIP receptors is disclosed. Uses of the triple agonist are disclosed.

Triple glucagon/GLP-1/GIP receptor agonist

A long-acting conjugate of a triple agonist which has activities to all of glucagon, GLP-1, and GIP receptors and uses thereof.

Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist

The present invention relates to a long-acting conjugate of a triple agonist having activities to all of glucagon, GLP-1, and GIP receptors and uses thereof.

The present invention relates to a triple agonist having activities to all of glucagon, GLP-1, and GIP receptors and uses thereof.

Growing community of inventors

Gyeonggi-do, South Korea

Jong Suk Lee